http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6384054-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebb6a553affdc364c91cffe3baf12564 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate | 2001-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e45ec7715fc656d45dbae913906d75f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99726ff5314b324275c32708318501d9 |
| publicationDate | 2002-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6384054-B1 |
| titleOfInvention | Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients |
| abstract | Methods and compositions are disclosed utilizing metabolic derivatives of astemizole for the treatment of allergic disorders while avoiding the concomitant liability of adverse effects associated with the astemizole. The metabolic derivatives of astemizole are also useful for the treatment of retinopathy and other small vessel disorders associated with diabetes mellitus and such other conditions as may be related to the antihistamine activity of astemizole. For example, the metabolic derivatives of astemizole are useful for the treatment of asthma, motion sickness, and vertigo, without the concomitant liability of adverse effects associated with astemizole. Furthermore, the metabolic derivatives of astemizole, in combination with non-steroidal anti-inflammatory agents or other non-narcotic analgesics, or in combination with a decongestant, cough suppressant/antitussive or expectorant, are useful for the treatment of cough, cold, cold-like, and/or flu symptoms and the discomfort, headache, pain, fever, and general malaise associated therewith, without the concomitant liability of adverse effects associated with astemizole. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015100312-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324727-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331307-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004186184-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8771643-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3639828-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9044465-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004253311-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4082550-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011014127-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11174206-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7863287-B2 |
| priorityDate | 1992-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.